For comparison, a 30 fold higher concentration of Her2 derived peptide, PDSLRDLSVF, amino acid 420–429, from the Her2/Neu breast cancer antigen [27] is required to induce antigen-specific T cell responses in a vaccine model for breast cancer [28]. This evidence concerns the gene ERBB2 and breast carcinoma.